Todd VanArsdale
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Immunology top 2%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
Papers in
- Oncology 27
- Cancer-related Molecular Pathways 11
-
- Protein Degradation and Inhibitors 4
- Cell death mechanisms and regulation 4
- Co-authors
- Carl F. Ware (11 shared papers)Paul D. Crowe (5 shared papers)Kim Arndt (5 shared papers)Robert T. Abraham (2 shared papers)Chris Boshoff (1 shared paper)Jeffrey L. Browning (2 shared papers)Michael J. Munchhof (2 shared papers)John P. Chute (1 shared paper)
- Journals
- Cancer Research (9 papers)The Journal of Immunology (4 papers)Clinical Cancer Research (3 papers)Journal of Cellular Biochemistry (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Todd VanArsdale
48 papers receiving 3.7k citations
Todd VanArsdale's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.3k
- Immunology 969
- Cancer Research 549
- Genetics 294
- Hematology 266
Countries citing papers authored by Todd VanArsdale
This map shows the geographic impact of Todd VanArsdale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd VanArsdale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd VanArsdale more than expected).
Fields of papers citing papers by Todd VanArsdale
This network shows the impact of papers produced by Todd VanArsdale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd VanArsdale. The network helps show where Todd VanArsdale may publish in the future.
Co-authors
The 25 scholars most cited alongside Todd VanArsdale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia Hit paper breakdown → | 2009 | 676 |
| 2 | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance Hit paper breakdown → | 2016 | 318 |
| 3 | 2015 | 304 | |
| 4 | 2018 | 253 | |
| 5 | 1995 | 218 | |
| 6 | 2014 | 215 | |
| 7 | 1997 | 178 | |
| 8 | 1999 | 159 | |
| 9 | 1991 | 154 | |
| 10 | 1997 | 151 | |
| 11 | 1996 | 139 | |
| 12 | 2020 | 120 | |
| 13 | 2015 | 117 | |
| 14 | 2009 | 92 | |
| 15 | 2023 | 81 | |
| 16 | 2017 | 73 | |
| 17 | 2010 | 60 | |
| 18 | 2020 | 57 | |
| 19 | 1993 | 53 | |
| 20 | 1994 | 44 |
About Todd VanArsdale
Todd VanArsdale is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 48 papers that have together received 3.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (17 papers), Cancer-related Molecular Pathways (11 papers), Immune Response and Inflammation (6 papers), Microtubule and mitosis dynamics (5 papers), NF-κB Signaling Pathways (5 papers), Cancer Genomics and Diagnostics (4 papers), Protein Degradation and Inhibitors (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (969 citations), Cancer Research (549 citations), Genetics (294 citations) and Hematology (266 citations). Todd VanArsdale has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Carl F. Ware, Paul D. Crowe, Kim Arndt, Robert T. Abraham, Chris Boshoff, Jeffrey L. Browning, Michael J. Munchhof, John P. Chute, Philip A. Beachy and Jordan Blum. Their work appears in journals such as Cancer Research, The Journal of Immunology, Clinical Cancer Research, Journal of Cellular Biochemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.